Skip to main content
SpringerLink
Log in

Thymosin β4 enhances endothelial cell differentiation and angiogenesis

  • Published:
Angiogenesis Aims and scope Submit manuscript

Abstract

When human umbilical vein endothelial cells (HUVEC) differentiate into capillary-like tubes, there is a five-fold upregulation of the mRNA for thymosin β4 (Tβ4) (Grant et al. J Cell Sci 1995; 108: 3685–94 [1]) and this endogenous expression plays an important role in endothelial cell attachment to and spreading on matrix components. We now show that exogenous addition of thymosin β4 (in the ng–μg range) to HUVEC in culture can induce several biological responses. These responses include increased tube formation in vitro. Additionally, exogenous thymosin β4 enhances vascular sprouting in the coronary artery ring angiogenesis assay. Measurements of these vascular sprouts show a doubling of the vessel area (via increased branching) with as little as 100 ng of synthetic thymosin β4. These processes appear to involve the binding of thymosin β4 to an unknown cell surface receptor and internalization of the protein. This cell surface-binding appears not to be mediated through the thymosin β4-actin binding domain LKTET. An increase in thymosin β4 cytoplasmic staining in HUVEC exposed 10 μg of the peptide appears to occur without increased mRNA translation. In summary Tβ4 induces an increase in cell-matrix attachment, proliferation, tube formation, internalization of the peptide and rearrangement of the actin cytoskeleton. The data now defines both an autocrine and paracrine role for thymosin β4 in vessel formation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Grant DS, Kinsella JL, Kibbey MC et al. Matrigel induces thymosin beta 4 gene in differentiating endothelial cells. J Cell Sci 1995; 108: 3685–94.

    PubMed  CAS  Google Scholar 

  2. Brown LF, Detmar M, Claffey K et al. Vascular permeability factor/vascular endothelial growth factor: A multifunctional angiogenic cytokine. Exs 1997; 79: 233–69.

    PubMed  CAS  Google Scholar 

  3. Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992; 267: 10931–4.

    PubMed  CAS  Google Scholar 

  4. Furcht LT. Critical factors controlling angiogenesis: Cell products, cell matrix, and growth factors. Lab Invest 1986; 55: 505–9.

    PubMed  CAS  Google Scholar 

  5. Grant DS, Kleinman HK. Regulation of capillary formation by laminin and other components of the extracellular matrix. Exs 1997; 79: 317–33.

    PubMed  CAS  Google Scholar 

  6. Ingber DE, Folkman J. How does extracellular matrix control capillary morphogenesis? Cell 1989; 58: 803–5.

    Article  PubMed  CAS  Google Scholar 

  7. Madri JA, Pratt BM. Endothelial cell-matrix interactions: In vitro models of angiogenesis. J Histochem Cytochem 1986; 34: 85–91.

    PubMed  CAS  Google Scholar 

  8. Grant DS, Kinsella JL, Fridman R et al. Interaction of endothelial cells with a laminin A chain peptide (SIKVAV) in vitro and induction of angiogenic behavior in vivo. J Cell Physiol 1992; 153: 614–25.

    Article  PubMed  CAS  Google Scholar 

  9. Low TLK, Goldstein AL. Chemical characterization of thymosin β4. J Biol Chem 1981; 257: 1000–6.

    Google Scholar 

  10. Low TL, Goldstein AL. Thymosin beta 4. Methods Enzymol 1985; 116: 248–55.

    Article  PubMed  CAS  Google Scholar 

  11. Bao L, Loda M, Janmey PA et al. Thymosin beta 15: A novel regulator of tumor cell motility upregulated in metastatic prostate cancer. Nat Med 1996; 2: 1322–8.

    Article  PubMed  CAS  Google Scholar 

  12. Li X, Zimmerman A, Copeland NG, Gilbert DJ et al. The mouse thymosin beta 4 gene: Structure, promoter identification, and chromosome localization. Genomics 1996; 32: 388–94.

    Article  PubMed  CAS  Google Scholar 

  13. Low T, Goldstein A. Thymosins: Structure, function and therapeutic application. Thymus 1984; 6: 27–42.

    PubMed  CAS  Google Scholar 

  14. Livaniou E, Mihelic M, Evangelatos GP et al. A thymosin beta 4 ELISA using an antibody against the N terminal fragment thymosin beta 4 [1–14]. J Immunol Methods 1992; 148: 9–14.

    Article  PubMed  CAS  Google Scholar 

  15. Clauss IM, Wathelet MG, Szpirer J et al. Human thymosin-beta 4/6–26 gene is part of a multigene family composed of seven members located on seven different chromosomes. Genomics 1991; 9: 174–80.

    Article  PubMed  CAS  Google Scholar 

  16. Safer D, Elzinga M, Nachmias VT. Thymosin beta 4 and Fx, an actin-sequestering peptide, are indistinguishable. J Biol Chem 1991; 266: 4029–32.

    PubMed  CAS  Google Scholar 

  17. Safer D, Nachmias VT. Beta thymosins as actin binding peptides. Bioessays 1994; 16.

  18. Vancompernolle K, Goethals M, Huet C et al. G-to F-actin modulation by a single amino acid substitution in the actin binding site of actobindin and thymosin beta 4. Embo J 1992; 11: 4739–46.

    PubMed  CAS  Google Scholar 

  19. Yu FX, Lin SC, Morrison BM, Yin HL. Effects of thymosin beta 4 and thymosin beta 10 on actin structures in living cells. Cell Motil Cytoskeleton 1994; 27: 13–25.

    Article  PubMed  CAS  Google Scholar 

  20. Carpintero P, Franco dAF, Anadon R, Gomez MJ. Thymosin beta10 mRNA expression during early postimplantation mouse development. Febs Lett 1996; 394: 103–6.

    Article  PubMed  CAS  Google Scholar 

  21. Gomez-Marquez J, Dosil M, Segade F et al. Thymosin-β4 gene: Preliminary characterisation and expression in tissues, thymic cells, and lymphocytes. J Immuno 1989; 143: 2740–4.

    CAS  Google Scholar 

  22. Carpinterio P, Anadon R, del AF, Gomez MJ. The thymosin beta 4 gene is strongly activated in neural tissues during early postimplantation mouse development. Neurosci Lett 1995; 184: 63–6.

    Article  PubMed  CAS  Google Scholar 

  23. Hall A. Differential expression of thymosin genes in human tumors and in the developing human kidney. Int J Can 1991; 48: 672–7.

    CAS  Google Scholar 

  24. Naylor PH, Friedman KA, Hersh E et al. Thymosin alpha 1 and thymosin beta 4 in serum: Comparison of normal, cord, homosexual and AIDS serum. Int J Immunopharmacol 1986; 8: 667–76.

    Article  PubMed  CAS  Google Scholar 

  25. Cordero OJ, Sarandeses C, Nogueira M. Prothymosin alpha receptors on peripheral blood mononuclear cells. FEBS Lett 1994; 341: 23–7.

    Article  PubMed  CAS  Google Scholar 

  26. Kleinman HK, McGarvey ML, Liotta LA et al. Isolation and characterization of type IV procollagen, laminin and heparan sulfate proteoglycan from the EHS sarcoma. Biochemistry 1986; 24: 6188.

    Google Scholar 

  27. Malinda KM, Goldstein AL, Kleinman HK. Thymosin β4 stimulates directional migration of human umbilical vein endothelial cells. FASEB 1997; 11: 474–81.

    CAS  Google Scholar 

  28. Grant DS, Tashiro K-I, Segui-Real B. et al. Two different laminin domains mediate the differentiation of human endothelial cells into capillary-like structures in vitro. Cell 1989; 58: 933–43.

    Article  PubMed  CAS  Google Scholar 

  29. Grant DS, Lelkes PI, Fukuda K, Kleinman HK. Intracellular mechanisms involved in basement membrane induced blood vessel differentiation in vitro. In Vitro Cell Dev Biol 1991; 21A: 327–36.

    Google Scholar 

  30. Soukos NS, Wilson M, Burns T, Speight PM. Photodynamic effects of toluidine blue on human oral keratinocytes and fibroblasts and Streptococcus sanguis evaluated in vitro. Lasers Surg Med 1996; 18: 253–59.

    Article  PubMed  CAS  Google Scholar 

  31. Grant DS, Kleinman HK, Martin GR. The role of basement membranes in vascular development. Ann NY Acad Sci 1990; 588: 61–72.

    PubMed  CAS  Google Scholar 

  32. Nicosia RF, Ottinetti A. Growth of microvessels in serum-free matrix culture of rat aorta. Lab Invest 1990; 63: 115–22.

    PubMed  CAS  Google Scholar 

  33. Nachmias VT. Small actin-binding proteins: The β-thymosin family. Curr Opin Cell Biol 1993; 5: 56–62.

    Article  PubMed  CAS  Google Scholar 

  34. Martinez J, Rich E, Barsigian C. Transglutaminase-mediated cross-linking of fibrinogen by human umbilical vein endothelial cells. JBC 1989; 264: 20502–8.

    CAS  Google Scholar 

  35. Martinez J, Rich E, Barsigian C. Transglutaminase-mediated cross-linking of fibrinogen by human umbilical vein endothelial cells. J Biol Chem 1989; 264: 20502–8.

    PubMed  CAS  Google Scholar 

  36. Shimamura R, Kudo J, Kondo H et al. Expression of the thymosin β4 gene during differentiation of hematopoietic cells. Blood 1990; 76: 977–84.

    PubMed  CAS  Google Scholar 

  37. Safer D, Nachmias VT. Beta thymosins as actin binding peptides [published erratum appeared in Bioessays Aug 1994; 16(8): 590]. Bioessays 1994; 16: 473–9.

    Article  PubMed  CAS  Google Scholar 

  38. Weller F, Mutchnik M. Exzyme immunoassay measurement of thymosin β4. J. Immunoassay 1987; 8: 203–17.

    PubMed  CAS  Google Scholar 

  39. Hannappel E, Kampen Mv. Determination of thymosin β4 in human blood cells and seurm. J Chrom 1987; 397: 279–85.

    Article  CAS  Google Scholar 

  40. Gold JS, Bao L, Ghoussoub RAD. et al. Localization and quantitation of expression of the cell motility-related protein thymosin β15 in human breast tissue. 1997; 10: 1106–12.

    CAS  Google Scholar 

  41. Frohm M, Gunne H, Bergman AC et al. Biochemical and antibacterial analysis of human wound and blister fluid. Eur J Biochem 1996; 237: 86–92.

    Article  PubMed  CAS  Google Scholar 

  42. Bonnet D, Lemoine FM, Frobert Y et al. Thymosin beta4, inhibitor for normal hematopoietic progenitor cells. Exp Hematol 1996; 24: 776–82.

    PubMed  CAS  Google Scholar 

  43. Gomez-Marquez J, Franco dAF, Carpintero P, Anadon R. High levels of mouse thymosin beta4 mRNA in differentiating P19 embryonic cells and during development of cardiovascular tissues. Biochim Biophys Acta 1996; 1306: 187–93.

    PubMed  Google Scholar 

  44. Sanders MC, Goldstein AL, Wang YL. Thymosin beta 4 (Fx peptide) is a potent regulator of actin polymerization in living cells. Proc Natl Acad Sci USA 1992; 89: 4678–82.

    Article  PubMed  CAS  Google Scholar 

  45. Golla R, Philip N, Safer D et al. Co-ordinate regulation of the cytoskeleton in 3T3 cells overexpressing thymosin-beta4. Cell Motil Cytoskeleton 1997; 38: 187–200.

    Article  PubMed  CAS  Google Scholar 

  46. Castro JM, Barcia MG. Localization of prothymosin alpha in the nucleus. Biochem Biophys Res Commun 1996; 224: 140–6.

    Article  PubMed  CAS  Google Scholar 

  47. Manrow RE, Sburlati AR, Hanover JA, Berger SL. Nuclear targeting of prothymosin alpha. J Biol Chem 1991; 266: 3916–24.

    PubMed  CAS  Google Scholar 

  48. Watts J, Cary P, Sautire P, Crane-Robinson C. Thymosins: Both nuclear and cytoplasmic proteins. Eur J Biochem 1990; 192: 643–51.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Cardeza Foundation for Hematologic Research, Thomas Jefferson University, Philadelphia, Pennsylvania, USA

    Derrick S. Grant, Wesley Rose, Christopher Yaen & Jose Martinez

  2. Department of Biochemistry, George Washington University, Washington, DC, USA

    Allan Goldstein

  3. Laboratory Developmental Biology, National Institute of Dental Research, NIH, Bethesda, Maryland, USA

    Hynda Kleinman

Authors
  1. Derrick S. Grant
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wesley Rose
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Christopher Yaen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Allan Goldstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jose Martinez
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hynda Kleinman
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grant, D.S., Rose, W., Yaen, C. et al. Thymosin β4 enhances endothelial cell differentiation and angiogenesis. Angiogenesis 3, 125–135 (1999). https://doi.org/10.1023/A:1009041911493

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1009041911493

Search

Navigation